|
Diabetes, Vol 35, Issue 6 668-674, Copyright © 1986 by American Diabetes Association
Acetone metabolism in humans during diabetic ketoacidosis
GA Reichard, CL Skutches, RD Hoeldtke and OE Owen
Plasma acetone turnover rates were measured with the primed continuous
infusion of 2-[14C]acetone in patients with moderate to severe diabetic
ketoacidosis. Plasma acetone turnover rates ranged from 1.52 to 15.9 mumol
X kg-1 X min-1 (108-1038 mumol X 1.73 m-2 X min-1) and were directly
related to the plasma acetone concentrations that ranged from 0.47 to 7.61
mM. The average acetone turnover rate was 6.45 mumol X kg-1 X min-1 (533
mumol X 1.73 m-2 X min-1), a value twice that obtained in a similar group
of diabetic ketoacidotic patients via the single-injection technique of
2-[14C]acetone administration. Degradation of urine glucose revealed that
14C from administered 2-[14C )acetone was principally located in carbons 1,
2, 5, and 6 of the glucose molecule in five of six patients. This
distribution is similar to that expected from 2-[14C]pyruvate, suggesting
that acetone was converted to glucose through pyruvate. In one patient,
label was located predominantly in glucose carbons 3 and 4, indicating that
acetone metabolism may be different in some patients. Acetol
(1-hydroxyacetone) and 1,2-propanediol (PPD), two possible metabolites of
acetone, were detected in plasma of the patients. The concentrations of
Acetol ranged from 0 to 0.48 mM and of PPD ranged from 0 to 0.53 mM. The
concentrations of each metabolite were directly related to the plasma
acetone concentrations. During the continuous infusion of 2-[14C]acetone,
the specific activities of plasma glucose and PPD rose continuously but did
not reach constant values. Estimates of the minimal percent plasma glucose
and PPD derived from plasma acetone averaged 2.1 and 74%, respectively.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. M. Biemel, D. A. Friedl, and M. O. Lederer
Identification and Quantification of Major Maillard Cross-links in Human Serum Albumin and Lens Protein. EVIDENCE FOR GLUCOSEPANE AS THE DOMINANT COMPOUND
J. Biol. Chem.,
July 5, 2002;
277(28):
24907 - 24915.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. C. Chang, K. S. Paek, H. J. Kim, Y. S. Lee, C. Yabe-Nishimura, and H. G. Seo
Substrate-Induced Up-Regulation of Aldose Reductase by Methylglyoxal, a Reactive Oxoaldehyde Elevated in Diabetes
Mol. Pharmacol.,
May 1, 2002;
61(5):
1184 - 1191.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. A. Voziyan, T. O. Metz, J. W. Baynes, and B. G. Hudson
A Post-Amadori Inhibitor Pyridoxamine Also Inhibits Chemical Modification of Proteins by Scavenging Carbonyl Intermediates of Carbohydrate and Lipid Degradation
J. Biol. Chem.,
January 25, 2002;
277(5):
3397 - 3403.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Murata-Kamiya and H. Kamiya
Methylglyoxal, an endogenous aldehyde, crosslinks DNA polymerase and the substrate DNA
Nucleic Acids Res.,
August 15, 2001;
29(16):
3433 - 3438.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. Kitabchi, G. E. Umpierrez, M. B. Murphy, E. J. Barrett, R. A. Kreisberg, J. I. Malone, and B. M. Wall
Management of Hyperglycemic Crises in Patients With Diabetes
Diabetes Care,
January 1, 2001;
24(1):
131 - 153.
[Full Text]
|
 |
|

|
 |

|
 |
 
T. Oya, N. Hattori, Y. Mizuno, S. Miyata, S. Maeda, T. Osawa, and K. Uchida
Methylglyoxal Modification of Protein. CHEMICAL AND IMMUNOCHEMICAL CHARACTERIZATION OF METHYLGLYOXAL-ARGININE ADDUCTS
J. Biol. Chem.,
June 25, 1999;
274(26):
18492 - 18502.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. B. Frye, T. P. Degenhardt, S. R. Thorpe, and J. W. Baynes
Role of the Maillard Reaction in Aging of Tissue Proteins. ADVANCED GLYCATION END PRODUCT-DEPENDENT INCREASE IN IMIDAZOLIUM CROSS-LINKS IN HUMAN LENS PROTEINS
J. Biol. Chem.,
July 24, 1998;
273(30):
18714 - 18719.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Che, M. Asahi, M. Takahashi, H. Kaneto, A. Okado, S. Higashiyama, and N. Taniguchi
Selective Induction of Heparin-binding Epidermal Growth Factor-like Growth Factor by Methylglyoxal and 3-Deoxyglucosone in Rat Aortic Smooth Muscle Cells. THE INVOLVEMENT OF REACTIVE OXYGEN SPECIES FORMATION AND A POSSIBLE IMPLICATION FOR ATHEROGENESIS IN DIABETES
J. Biol. Chem.,
July 18, 1997;
272(29):
18453 - 18459.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1986 by the American Diabetes Association.
|
|
| |
|